Clinical Trial Update: Montreal Heart Attack Readjustment Trial (M-HART) [Phase 3]

View source ↗

Summary

Phase 3 Montreal Heart Attack Readjustment Trial (M-HART) sponsored by McGill University has completed. The trial addresses cardiovascular conditions including …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Coronary Artery Disease
• Heart Disease
• Myocardial Infarction
• Myocardial Ischemia

Snippet

Sponsor: McGill University | Conditions: Cardiovascular Diseases, Coronary Disease | Phase 3 | Status: COMPLETED